- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Expanding Medicaid Could Save Idaho Hundreds of Millions of Dollars
A governor-appointed panel said expanding Medicaid via an alternative funding plan they developed would save Idaho $173 million over the next 10 years.
Members of the governor-appointed panel that looked at options for expanding Medicaid to cover 103,000 of Idaho’s poorest adults told lawmakers Thursday that not expanding the program had cost the state “hundreds of millions of dollars” in federal healthcare funds that Idaho taxpayers are due under federal healthcare reform.
The panel members said expanding Medicaid now via an alternative funding plan they developed, giving the state more control over how funds are spent, would save Idaho $173 million over the next 10 years.
The federal government has already approved similar alternative plans in other states where Medicaid expansion has been politically or ideologically unpopular.
Read more: http://bit.ly/1DRhW2h
Source: Idaho Statesman
Read more here: http://www.idahostatesman.com/2015/02/05/3630009_panel-tells-lawmakers-state-has.html?rh=1#storylink=cpy
Review Emphasizes Potential Infection Risks With BTK Inhibitors
November 2nd 2024Although Bruton tyrosine kinase (BTK) inhibitor monotherapy in chronic lymphocytic leukemia (CLL) has been a game-changer, patients have significantly increased risks of infection, especially in the upper respiratory tract.
Read More
Sustaining Compassionate Trauma Care Across Communities
September 30th 2024September is National Recovery Month, and we are bringing you another limited-edition month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In our final episode, we speak with Lyndra Bills, MD, and Shari Hutchison, MS.
Listen
PAH Treatment Outcomes Similar Regardless of Diagnosis Time
November 1st 2024The study findings underscore the importance of early initiation of macitentan and tadalafil among patients who have pulmonary arterial hypertension (PAH), and represent a shift in understanding of prognosis based on diagnosis timing.
Read More
